US Broker Ratings

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Growth in the Pharmaceutical Sector

Dr. Reddy’s Laboratories Ltd (RDY), a prominent player in the healthcare sector, is making waves in the pharmaceutical industry with its diverse portfolio and solid growth metrics. Headquartered in Hyderabad,..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unpacking the 64% Potential Upside for Investors

Akero Therapeutics, Inc. (NASDAQ: AKRO) is capturing the attention of investors with a promising upside potential of 64.37%. Specializing in the healthcare sector, specifically within the biotechnology industry, Akero Therapeutics..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Deep Dive into 49.14% Potential Upside

In the dynamic world of medical devices, Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out with its innovative approach to treating obstructive sleep apnea (OSA). This U.S.-based company, headquartered in..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 34.83% Potential Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), based in Dublin, Ireland, is a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of..

TG Therapeutics (TGTX) Stock Analysis: Exploring a 19% Upside in the Biotech Sector

TG Therapeutics, Inc. (TGTX), a biopharmaceutical company based in Morrisville, North Carolina, is gaining traction in the healthcare sector, particularly within the biotechnology industry. With a market cap of $5.49..

Exact Sciences Corporation (EXAS) Stock Analysis: Exploring a 20.86% Potential Upside in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specifically in diagnostics and research, is capturing investor attention with a robust potential upside of 20.86%. Specializing in..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Strong Analyst Support Despite High Valuation Challenges

iRhythm Technologies, Inc. (NASDAQ: IRTC), a key player in the medical devices industry, continues to make significant strides in the healthcare sector. Specializing in ambulatory cardiac monitoring services, iRhythm has..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unpacking the 140% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK) is generating significant buzz in the biotech sector, captivating investor attention with a staggering 140.50% potential upside, as reflected in its average target price. With a..

IDEXX Laboratories, Inc. (IDXX) Stock Report: Navigating Growth in the Diagnostics & Research Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading player in the healthcare sector, is renowned for its innovative contributions to the diagnostics and research industry. With a market capitalization of $40.34..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising 82% Upside Potential in Targeted Cancer Therapies

Revolution Medicines, Inc. (NASDAQ: RVMD) emerges as a compelling opportunity for investors keen on ventures at the forefront of oncology. Specializing in precision medicine, this biotech firm is charting a..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Promising Growth Potential

Exelixis, Inc. (NASDAQ: EXEL) stands as a formidable player in the biotechnology industry, specializing in developing breakthrough cancer therapies. With a market capitalization of $11.56 billion, this U.S.-based oncology company..

CVS Health Corporation (CVS) Investor Outlook: Unpacking a 30% Upside Potential

CVS Health Corporation (CVS), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and promising potential for upside. With a market capitalization of..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Potential 31.63% Upside with Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) has emerged as a dynamic player in the biotechnology sector, captivating investor interest with its strategic focus on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: 26% Potential Upside and Strong Buy Ratings Spark Investor Interest

GE HealthCare Technologies Inc. (GEHC) stands as a significant player in the healthcare industry, particularly within the health information services sector. With a market capitalization of $31.67 billion, this U.S.-based..

The Cooper Companies, Inc. (COO): Investor Outlook with 33.90% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a significant player in the healthcare sector, specifically in the medical instruments and supplies industry, offers a compelling opportunity for investors seeking exposure to..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: High Analyst Confidence and a Promising 76% Upside Potential

BridgeBio Pharma, Inc. (BBIO), a leading player in the biotechnology sector, is capturing investor attention with its innovative approach to treating genetic diseases and cancers. With a market capitalization of..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring an 18% Upside Potential with Strong Buy Ratings

For investors looking to navigate the healthcare sector, Molina Healthcare Inc (NYSE: MOH) stands out as a compelling opportunity, particularly in light of its robust growth metrics and analysts’ favorable..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 29% Potential Upside in the Medical Device Sector

Teleflex Incorporated (NYSE: TFX), a notable player in the healthcare sector, has captured attention with its diversified portfolio of single-use medical devices. With a current market capitalization of $5.34 billion,..

The Cigna Group (CI) Stock Analysis: A Healthcare Giant with an 18.74% Potential Upside

For investors on the lookout for promising opportunities in the healthcare sector, The Cigna Group (NYSE: CI) offers an intriguing prospect. With a market capitalization of $84.41 billion, Cigna stands..

Summit Therapeutics Inc. (SMMT): Biotech Stock with a 47% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) is capturing the attention of investors within the biotechnology sector, not only for its groundbreaking approach to drug development but also for its significant potential..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds